IN2012DN00719A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00719A IN2012DN00719A IN719DEN2012A IN2012DN00719A IN 2012DN00719 A IN2012DN00719 A IN 2012DN00719A IN 719DEN2012 A IN719DEN2012 A IN 719DEN2012A IN 2012DN00719 A IN2012DN00719 A IN 2012DN00719A
- Authority
- IN
- India
- Prior art keywords
- compounds
- disorders
- compositions
- useful
- cftr
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23274109P | 2009-08-10 | 2009-08-10 | |
PCT/US2010/045052 WO2011019737A1 (en) | 2009-08-10 | 2010-08-10 | Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00719A true IN2012DN00719A (xx) | 2015-06-19 |
Family
ID=43586433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN719DEN2012 IN2012DN00719A (xx) | 2009-08-10 | 2010-08-10 |
Country Status (6)
Country | Link |
---|---|
US (1) | US8609661B2 (xx) |
EP (1) | EP2464354B1 (xx) |
CN (1) | CN102695510A (xx) |
CA (1) | CA2769847C (xx) |
IN (1) | IN2012DN00719A (xx) |
WO (1) | WO2011019737A1 (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9062073B2 (en) * | 2011-05-27 | 2015-06-23 | The Regents Of The University Of California | Pyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses therefor |
CN105143230B (zh) | 2012-12-19 | 2017-06-09 | 诺华股份有限公司 | 用于抑制cftr通道的三环化合物 |
ES2650372T3 (es) * | 2012-12-19 | 2018-01-18 | Novartis Ag | Compuestos tricíclicos como inhibidores de CFTR |
GB201905711D0 (en) * | 2019-04-24 | 2019-06-05 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of kidney diseases |
CN114948966B (zh) * | 2022-04-27 | 2023-06-20 | 南京鼓楼医院 | 一种小分子抑制剂在制备治疗多发性硬化和脓毒症的药物中的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2751969B1 (fr) * | 1996-08-01 | 1998-12-04 | Centre Nat Rech Scient | Composes activateurs du canal cftr, et compositions pharmaceutiques les contenant |
GB9626643D0 (en) * | 1996-12-21 | 1997-02-12 | Astra Pharma Prod | Compounds |
US7235573B2 (en) | 2002-09-30 | 2007-06-26 | The Regents Of The University Of California | Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors |
ATE440825T1 (de) | 2003-06-06 | 2009-09-15 | Vertex Pharma | Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern |
FR2861304B1 (fr) | 2003-10-23 | 2008-07-18 | Univ Grenoble 1 | Modulateurs des canaux cftr |
CN1960966A (zh) | 2004-03-30 | 2007-05-09 | 加利福尼亚大学董事会 | 含酰肼cftr抑制剂化合物及其用途 |
US7563793B2 (en) * | 2004-12-20 | 2009-07-21 | Wyeth | Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents |
EP2142498A2 (en) * | 2007-04-02 | 2010-01-13 | Institute for Oneworld Health | Cftr inhibitor compounds and uses thereof |
JP5637859B2 (ja) | 2007-12-13 | 2014-12-10 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | 嚢胞性線維症膜コンダクタンスレギュレーターのモジュレーター |
AU2009228307A1 (en) | 2008-03-25 | 2009-10-01 | The Regents Of The University Of California | Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
JP2011516499A (ja) | 2008-04-04 | 2011-05-26 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 嚢胞性線維症膜コンダクタンス制御因子を阻害するための二価ヒドラジド化合物コンジュゲート |
US9062073B2 (en) | 2011-05-27 | 2015-06-23 | The Regents Of The University Of California | Pyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses therefor |
-
2010
- 2010-08-10 US US13/389,898 patent/US8609661B2/en active Active
- 2010-08-10 WO PCT/US2010/045052 patent/WO2011019737A1/en active Application Filing
- 2010-08-10 CN CN2010800427350A patent/CN102695510A/zh active Pending
- 2010-08-10 CA CA2769847A patent/CA2769847C/en active Active
- 2010-08-10 IN IN719DEN2012 patent/IN2012DN00719A/en unknown
- 2010-08-10 EP EP10808643.0A patent/EP2464354B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2464354A1 (en) | 2012-06-20 |
WO2011019737A1 (en) | 2011-02-17 |
US8609661B2 (en) | 2013-12-17 |
EP2464354B1 (en) | 2015-04-01 |
US20120208822A1 (en) | 2012-08-16 |
CA2769847C (en) | 2019-01-08 |
CA2769847A1 (en) | 2011-02-17 |
CN102695510A (zh) | 2012-09-26 |
EP2464354A4 (en) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010010343A (es) | Inhibidores solubles en agua de molecula pequeña del regulador de conductancia transmembrana de fibrosis quistica. | |
MX2009008347A (es) | Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso. | |
WO2007129226A3 (en) | Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders | |
MX2007009807A (es) | Agentes terapeuticos de aptameros utiles en el tratamiento de trastornos relacionados con el complemento. | |
WO2008154251A3 (en) | C3b antibodies and methods for the prevention and treatment of complement- associated disorders | |
WO2008147797A3 (en) | Ion channel modulators and methods of use | |
GB2463833A (en) | Methods and compositions for the treatment of neurological disorders | |
TW200604192A (en) | Compounds and methods for inhibiting mitotic progression | |
WO2009023509A3 (en) | Therapeutic combinations useful in treating cftr related diseases | |
WO2007064857A8 (en) | Amphoteric liposome formulation | |
EP3632444A3 (en) | Topical lfa-1 antagonists for use in localized treatment of immune related disorders | |
WO2010059004A3 (ko) | 스네일-p53 간의 결합을 저해하는 화합물 및 이를 유효성분으로 함유하는 암질환 치료제 | |
IN2012DN00719A (xx) | ||
IL190632A0 (en) | Biphenyl derivatives and pharmaceutical compositions containing the same | |
WO2009146144A3 (en) | Divalent hydrazide compound conjugates for inhibiting cystic fibrosis transmembrane conductance regulator | |
WO2010009478A3 (en) | Compositions and methods for treating disorders associated with overweight animals | |
EA201071248A1 (ru) | Дизамещенные фталазиновые антагонисты пути hedgehog | |
IN2012DN02471A (xx) | ||
WO2008144223A3 (en) | Triazolyl aminopyrimidine compounds | |
WO2006092741A3 (en) | Treatment of inflammatory disorders with praziquantel | |
WO2012158672A3 (en) | Compounds for use in treatment of mucositis | |
WO2009158374A3 (en) | Inhibitors of akt activity | |
WO2012078867A3 (en) | Cycloalkyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | |
WO2009009034A3 (en) | Methods and compositions useful in the treatment of mucositis | |
HK1150401A1 (en) | Assay system for the assessment of oncogenicity, tumor progression, and treatment efficacy |